(Total Views: 566)
Posted On: 08/17/2020 10:41:19 PM
Post# of 151758
Re: nicehedges #50125
Wow, might do a ph3 with "100" patients. Now where have i heard that before?? lol
Good to hear NASDAQ has already responded.
Wonder why EUA w/ a ph4 wasn't mentioned by Nader? That would be my preference and let the severe trial cover our ph3 needs.
Still puzzled by the fact viral load wasn't a data point recorded as was BP.
Good to hear NASDAQ has already responded.
Wonder why EUA w/ a ph4 wasn't mentioned by Nader? That would be my preference and let the severe trial cover our ph3 needs.
Still puzzled by the fact viral load wasn't a data point recorded as was BP.
(1)
(1)Scroll down for more posts ▼
